Zillow Group, Inc. (NASDAQ:Z)
Zillow Group, Inc. offers real estate and home-related brands on mobile and web. The company’s brands focus on home lifecycle consists of renting, buying, selling, financing and home improvement. Its real estate and rental marketplaces of consumer brands includes Zillow(R) & Trulia(R) & StreetEasy(R) and HotPads(R). The company also works with real estate agents, lenders and rental professionals. Its business brands for real estate, rental and mortgage professionals, including Postlets(R) & Mortech(R) & Diverse Solutions(R) & Market Leader(R) and Retsly(TM). Zillow Group, Inc. is headquartered in Seattle.
Zillow Group, Inc. (NASDAQ:Z)’s Financial Overview
Zillow Group, Inc. (NASDAQ) surged 4.96% yesterday to close its trading session at $35.99. The company has 1 year Price Target of $37.67. Zillow Group, Inc. has 52-Week high of $65.7 and 52-Week Low of $26.38. The stock touched its 52-Week High on 65.70 and 52-Week Low on 26.38. The stock traded with the volume of 2.83 Million shares yesterday. The firm shows the market capitalization of $5 Billion.
Zillow Group, Inc. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.18/share against the analyst consensus estimate of $0.17/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 5.9%.
The firm is trading with SMA20 of 7.56 Percent, SMA50 of 8.78 Percent and SMA200 of -20.72 percent. Zillow Group, Inc. has P/S value of 4 while its P/B value stands at 2.2. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 18 analysts offering 12-month price forecasts for Zillow Group Inc have a median target of 39.00, with a high estimate of 70.00 and a low estimate of 23.00. The median estimate represents a +8.36% increase from the last price of 35.99.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Omeros Corporation (NASDAQ:OMER)
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros’ most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Omeros Corporation (NASDAQ:OMER)’s Financial Outlook
The 3 analysts offering 12-month price forecasts for Omeros Corp have a median target of 32.00, with a high estimate of 34.00 and a low estimate of 20.00. The median estimate represents a +137.92% increase from the last price of 13.45.
Omeros Corporation is estimated to report earnings on 03/07/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.75. The reported EPS for the same quarter last year was $-0.25.
According to Zacks Investment Research, Omeros Corporation has a Consensus Recommendation of 2. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined -0.44% and closed its last trading session at $13.45. The company has the market capitalization of $651.79 Million. The stock has 52-week high of $27 and 52-Week low of $8.36. The firm touched its 52-Week high on 27.00 and 52-Week low on 8.36. The company has volume of 245516 shares. The company has a total of 48.46 Million shares outstanding.
Omeros Corporation (NASDAQ) in the last quarter reported its actual EPS of $-0.81/share where the analyst estimated EPS was $-0.77/share. The difference between the actual and Estimated EPS is $-0.04. This shows a surprise factor of -5.2 percent.
The company has YTD performance of 20.74 percent. Beta for Omeros Corporation stands at 3.59 while its ATR (average true range) is 0.6. The company has Weekly Volatility of 3.43%% and Monthly Volatility of 4.89%%.
Omeros Corporation has distance from 20-day Simple Moving Average (SMA20) of 1.33%, Distance from 50-Day Simple Moving Average of 3.9 percent and Distance from 200-Day Simple Moving Average of -23.36%.
The Company currently has ROA (Return on Assets) of -123.7 percent, Return on Equity (ROE) of 270.2 Percent and Return on Investment (ROI) of -53.7% with Gross margin of 96.2 percent and Operating & Profit margin of 0% and 0% respectively.